Stryker Biotech clinical trials
Formerly part of Stryker, Feb 1, 2011 · source ↗
The registry lists 3 studies whose lead sponsor is Stryker Biotech. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 1, 2012.
Before and after it left Stryker
- First submitted before Stryker Biotech left Stryker
- 3
- First submitted after Stryker Biotech left Stryker
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Stryker Biotech3 studies
Something wrong with this grouping? Tell us on the Stryker page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Stryker studies →
- Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the KneeCompletedNCT01133613Phase 1
Sponsor listed in the registry: Stryker Biotech · First submitted before Stryker Biotech left Stryker
- Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the KneeCompletedNCT01111045Phase 2
Sponsor listed in the registry: Stryker Biotech · First submitted before Stryker Biotech left Stryker
- A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the KneeCompletedNCT00456157Phase 1
Sponsor listed in the registry: Stryker Biotech · First submitted before Stryker Biotech left Stryker